House Health Policy Hears Testimony on 340B LegislationThe House Health Policy Committee took up recently introduced legislation addressing 340B contract pharmacy arrangements during the week of Sept. 22. House Bill 4878, sponsored by Rep. Curt VanderWall (R-Ludington), was recently introduced and …
U.S. Senate Approves SUPPORT Act Reauthorization to Address Opioid and Mental Health CrisisThe U.S. Senate passed the SUPPORT for Patients and Communities Reauthorization Act of 2025 on Sept. 18. The bill would provide more resources for preventing and treating addiction and mental illness. It passed the U.S. …
Vault Verify’s Role in HR Automation Featured in PodcastMHA Endorsed Business Partner Vault Verify was recently featured on the RPI Tech Connect podcast episode “From Manual to Measurable: How UMMS Streamlined HR with RPI and Vault Verify.” Rebecca Hielke from the University of …
MHA Keystone Center PSO Hosts Human Errors and Design Thinking Safe TableRegistration is open for the MHA Keystone Center Patient Safety Organization (PSO) Human Errors and Design Thinking Safe Table. The event will be held from 10 a.m. to 3 p.m. on Oct. 1 at the …
Catching Up on All Things Healthcare with Tina Freese DeckerThe MHA released a new episode of the MiCare Champion Cast exploring state and federal healthcare priorities with Tina Freese Decker, MHA, MSIE, FACHE, president & CEO, Corewell Health and 2025 chair of the American …
Responding to Trump Healthcare 2.0: Key Takeaways after 8 Months
“The Trump 2.0 administration is 8-months into its MAGA agenda. Summer has passed. Schools are open. Congress is in session. Campaign 2026 is underway. The economy is slowing and public sentiment is dropping.
For U.S. healthcare, it’s more bad news than good. The challenges are unprecedented. Most organizations—hospitals, medical groups, drug and device makers, infomediaries and solution providers, insurers, et al—are defaulting to lower risk bets since the long-term for the health system is unclear.
The good news is that the health system in the U.S. is big, fragmented, complex, expensive (5% CAGR spending increases thru 2034) and slow to change. It is highly regulated at local, state and federal levels, labor intense (20 million) and capital-dependent (government funding, private investment)—a trifecta nightmare for operators and goldmine for private investors who time the system for shareholders effectively. And it operates opaquely: business practices are hidden from everyday users and bona-fide measures of its effectiveness not widely applied or accepted. …
Trump Healthcare 2.0 is not transformational: it is transactional. It aims to simplify the system and facilitate changes certain to disrupt the status quo. Its locus of control, is Main Street USA. not Pennsylvania Ave, in DC.”
Phone: (517) 703-8601
Fax: (517) 703-0628
